Benign prostatic hypertrophy
Conditions
Interventions
None listed
Sponsors
Local Incorporated Administrative Agency Kurate Hospital
Eligibility
Sex/Gender
Male
Inclusion criteria
Inclusion criteria: 1.??Patients undergoing WAVE for benign prostatic hyperplasia 2.??Individuals who do not meet any of the exclusion criteria listed below and have consented to forgo preoperative antibiotic administration for WAVE 3.??Individuals who have provided informed consent to participate in the study
Exclusion criteria
Exclusion criteria: 1. Patients with an indwelling urinary catheter 2. Patients with a clinically evident urinary tract infection prior to surgery 3. Patients with pyuria (5- WBCs per high-power field) or bacteriuria on urinalysis conducted the day before or on the day of surgery 4. Patients undergoing treatment with steroids or immunosuppressive agents 5. Patients with poorly controlled diabetes mellitus. "Poorly controlled diabetes" is defined as having an HbA1c higher than 8.5% within the past 3 months, or fasting blood glucose higher than 180 mg/dL / random blood glucose higher than 250 mg/dL confirmed on at least two occasions, or as determined by the physician to have poor glycemic control 6. Any other individuals deemed inappropriate for study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Incidence of genitourinary infections following WAVE | — |
Secondary
| Measure | Time frame |
|---|---|
| Association between infection, surgical procedures and patient characteristics | — |
Countries
Japan
Contacts
Public ContactNaohiro Fujimoto
Local Incorporated Administrative Agency Kurate Hospital Department of Urology
Outcome results
None listed